Ryvu Therapeutics S.A. (WSE:RVU)
Poland
· Delayed Price · Currency is PLN 30.25
+0.25 (0.83%)
Jun 6, 2025, 5:00 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Novel Small Molecule Therapies | 46.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Novel Small Molecule Therapies Growth | 20.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bioinformatics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bioinformatics Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Exclusion Income between Segments | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| European Union Countries | 41.66M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| European Union Countries Growth | 69.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries | 5.16M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries Growth | -63.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Poland | 38.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Poland Growth | -64.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|